Nenad Bartonicek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nenad Bartonicek has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Swarbrick
Cancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, Australia
42 shared publications - Daniel Lee Roden
Garvan Institute of Medical Research 1 Cancer Ecosystems Program Darlinghurst, Australia
41 shared publications - Joakim Lundeberg
Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden
41 shared publications - Kate Harvey
Garvan Institute of Medical Research
41 shared publications - Sunny Z. Wu
Genentech
41 shared publications - Anthony Michael Joshua
Kinghorn Cancer Centre, St Vincent's Hospital Sydney Australia
40 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- p. OF1-OF17
Sensitivity of Pancreatic Adenocarcinoma Cells to Blockade of Post-initiation CDK-Dependent Pol II Transcription Cycle Checkpoints
Pancreatic adenocarcinoma (PDAC) is a leading cause of cancer-related morbidity, with oncogenic KRAS/MAPK/ERK signaling arising from activating KRAS mutations being the key feature of this malignancy. Dysregulation of RNA polymerase II (Pol II)–dependent transcription is a universal hallmark of cancers, including PDAC, with aberrant gene expression programs driving tumorigenesis and influencing therapy response. Pol II progression through multiple transcription cycle checkpoints depends on transcriptional cyclin-dependent kinases (tCDK), and targeted inhibition of distinct tCDKs has been shown to be a promising anticancer strategy. In this study, we profile biological and molecular PDAC cell responses to selective blockade of tCDK kinase activity at all Pol II transcription cycle checkpoints, alone and in combination with inhibitors of mutant KRAS or MEK. We identify post–transcription-initiation checkpoints controlled by CDK9, CDK11, and CDK12/13 as critical for nascent gene expression and cell proliferation in PDAC. However, although dual targeting of tCDK and KRAS/MAPK/ERK networks amplifies transcriptomic phenotypes, this results in limited cooperative therapeutic impacts.
- 30 September 2026
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- p. OF1-OF17
Open AccessSensitivity of Pancreatic Adenocarcinoma Cells to Blockade of Post-initiation CDK-Dependent Pol II Transcription Cycle Checkpoints
Pancreatic adenocarcinoma (PDAC) is a leading cause of cancer-related morbidity, with oncogenic KRAS/MAPK/ERK signaling arising from activating KRAS mutations being the key feature of this malignancy. Dysregulation of RNA polymerase II (Pol II)–dependent transcription is a universal hallmark of cancers, including PDAC, with aberrant gene expression programs driving tumorigenesis and influencing therapy response. Pol II progression through multiple transcription cycle checkpoints depends on transcriptional cyclin-dependent kinases (tCDK), and targeted inhibition of distinct tCDKs has been shown to be a promising anticancer strategy. In this study, we profile biological and molecular PDAC cell responses to selective blockade of tCDK kinase activity at all Pol II transcription cycle checkpoints, alone and in combination with inhibitors of mutant KRAS or MEK. We identify post–transcription-initiation checkpoints controlled by CDK9, CDK11, and CDK12/13 as critical for nascent gene expression and cell proliferation in PDAC. However, although dual targeting of tCDK and KRAS/MAPK/ERK networks amplifies transcriptomic phenotypes, this results in limited cooperative therapeutic impacts.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S13 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 13 shows UMAPs and CNV profiles revealing copy number alterations in Basal and Club epithelial cell clusters in adjacent-benign and cancer cores for two patients.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S13 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 13 shows UMAPs and CNV profiles revealing copy number alterations in Basal and Club epithelial cell clusters in adjacent-benign and cancer cores for two patients.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S11 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 11 shows CopyKAT-based CNV classifications of epithelial cells in cancer and adjacent-benign cores, alongside enrichment of published prostate cancer signatures in normal prostate (Henry et al., 2018) and the PCa atlas dataset.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S11 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 11 shows CopyKAT-based CNV classifications of epithelial cells in cancer and adjacent-benign cores, alongside enrichment of published prostate cancer signatures in normal prostate (Henry et al., 2018) and the PCa atlas dataset.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Localized prostate cancers are heterogeneous and multifocal, with diverse outcomes. Current prognostic methods are epithelium-centric, overlooking the complex cellular landscape within the tumor microenvironment (TME). To further characterize the heterogeneity of the TME, we performed a comprehensive analysis of cancerous and adjacent-benign cores from 24 patients with hormone therapy–naïve localized prostate cancer using single-cell RNA sequencing (scRNA-seq). Integrating copy-number variation and transcriptional signatures enabled epithelial cell classification across a malignant spectrum, revealing widespread molecular perturbation. The analysis revealed patient-unique and shared luminal states and an expansion of club cell phenotypes, suggesting luminal dedifferentiation. Detailed annotation of stromal phenotypes, with a focus on fibroblasts, identified a perineural fibroblast population. Spatial transcriptomics elucidated the precise anatomic distribution of cancer-associated fibroblasts within the prostate cancer TME. Together, this study provides a valuable foundation for advancing the understanding of prostate cancer pathobiology and developing a comprehensive cellular model of the disease.Significance:Development of a single-cell RNA-sequencing and spatial transcriptomics cellular reference of localized prostate cancer enables identification of a spectrum of malignant epithelial phenotypes and discovery of a perineural class of fibroblast.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Localized prostate cancers are heterogeneous and multifocal, with diverse outcomes. Current prognostic methods are epithelium-centric, overlooking the complex cellular landscape within the tumor microenvironment (TME). To further characterize the heterogeneity of the TME, we performed a comprehensive analysis of cancerous and adjacent-benign cores from 24 patients with hormone therapy–naïve localized prostate cancer using single-cell RNA sequencing (scRNA-seq). Integrating copy-number variation and transcriptional signatures enabled epithelial cell classification across a malignant spectrum, revealing widespread molecular perturbation. The analysis revealed patient-unique and shared luminal states and an expansion of club cell phenotypes, suggesting luminal dedifferentiation. Detailed annotation of stromal phenotypes, with a focus on fibroblasts, identified a perineural fibroblast population. Spatial transcriptomics elucidated the precise anatomic distribution of cancer-associated fibroblasts within the prostate cancer TME. Together, this study provides a valuable foundation for advancing the understanding of prostate cancer pathobiology and developing a comprehensive cellular model of the disease.Significance:Development of a single-cell RNA-sequencing and spatial transcriptomics cellular reference of localized prostate cancer enables identification of a spectrum of malignant epithelial phenotypes and discovery of a perineural class of fibroblast.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Tab 4 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Table 4 shows the media and buffers used in sample collection, storage, and processing.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Tab 4 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Table 4 shows the media and buffers used in sample collection, storage, and processing.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S16 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 16 profiles the smooth muscle cell (SMC) lineage in the PCa microenvironment, showing minor SMC annotations, cell type abundances, top DEGs, key marker expression, and enriched biological processes.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S16 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 16 profiles the smooth muscle cell (SMC) lineage in the PCa microenvironment, showing minor SMC annotations, cell type abundances, top DEGs, key marker expression, and enriched biological processes.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S19 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 19 shows spatial plots for 8 additional Visium samples (beyond Fig. 5A), displaying histopathological annotations and k-means clusters from Space Ranger, highlighting the alignment between histology and gene-expression clustering.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S19 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 19 shows spatial plots for 8 additional Visium samples (beyond Fig. 5A), displaying histopathological annotations and k-means clusters from Space Ranger, highlighting the alignment between histology and gene-expression clustering.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S10 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 10 shows enrichment of epithelial lineage and TMRPSS2-ERG fusion signatures, canonical epithelial marker expression by minor and subset annotations, and subset-level cell numbers in cancer versus adjacent-benign cores.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S10 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 10 shows enrichment of epithelial lineage and TMRPSS2-ERG fusion signatures, canonical epithelial marker expression by minor and subset annotations, and subset-level cell numbers in cancer versus adjacent-benign cores.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Fig S23 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 23 complements the Visium deconvolution data, showing correlation between Cepo-derived pnCAF and PNS_glial signatures, suggesting co-localization of these cell types, particularly in nerve-enriched samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Fig S23 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Figure 23 complements the Visium deconvolution data, showing correlation between Cepo-derived pnCAF and PNS_glial signatures, suggesting co-localization of these cell types, particularly in nerve-enriched samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supp Tab 8 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Table 8 shows the genes used in the manual revision of the major cell type annotation level.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Tab 8 from Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
Supplementary Table 8 shows the genes used in the manual revision of the major cell type annotation level.